
Ka Lung Cheung, PhD
About Me
I run a lab in the Department of Pharmacological Sciences at Icahn School of Medicine at Mount Sinai in New York. I received my Ph.D. degree from Rutgers, State University of New Jersey, and worked as a postdoc in Icahn School of Medicine before promotion to Assistant Professor. My research laboratory is directed at better understanding the basic cellular and molecular mechanisms of immune cell-related inflammation and tissue regeneration. We employ an interdisciplinary research approach that relies on genomic sequencing, epigenetics, chemical biology, and transgenic mouse models to understand regulation of gene transcription in chromatin at the basic molecular level. We are particularly interested in studies of discovery of novel drug targets and their functional mechanisms in immune cell regulation and pathogenicity, epigenetic regulation of the intestinal homeostasis and regeneration, and crosstalk of pathogenic cell niche between hematopoietic cells and non-hematopoietic cells in inflammatory diseases.
Language
English
Position
ASSISTANT PROFESSOR | Pharmacological Sciences
Research Topics
Allergy, Alzheimer's Disease, Cell Biology, Cellular Differentiation, Cellular Immunity, Chromatin, Cytokines, Demyelination, Differentiation, Epithelial Cells, Gastroenterology, Gene Expressions, Gene Regulation, Immunology, Inflammation, Inflammatory Bowel Disease (IBD), Knockout Mice, Macrophage, Microglia, Molecular Biology, Mucosal Immunology, Multiple Sclerosis, Myelination, Protein Complexes, T Cells, Transcription Factors, Transcriptional Activation and Repression
Multi-Disciplinary Training Areas
Disease Mechanisms and Therapeutics (DMT), Immunology [IMM]
Download the CVEducation
BSc, University of Hong Kong
PhD, Rutgers, State University of New Jersey
Postdoc, Icahn Mount Sinai School of Medicine
Awards
2023
R01AI177461
NIH
2022
R01AI168004
NIH
2018
Crohn’s & Colitis Foundation of America (CCFA) Career Development Award
Crohn’s & Colitis Foundation of America
Publications
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Cheung has not yet completed reporting of industry relationships or has no industry relationships to report.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.